circVAMP3 is a potential prognostic indicator for HCC and may serve as a therapeutic target for HCC treatment.
circVAMP3 Drives CAPRIN1 Phase Separation and Inhibits Hepatocellular Carcinoma by Suppressing c-Myc Translation.